Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ENTG vs GSK✓SelectedUSD · GSKENTG vs GSK performance historyLatest closeAs of-3.92%11/19
Stock and ETF performance explorer

ENTG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+681.6%
GSK return
+97.7%
Excess return
+583.9%
Maximum drawdown
-59.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.9%-1.6%-2.4%-3.5%
7D-9.8%-4.7%-5.1%-8.7%
30D-3.3%-4.7%+1.4%-2.3%
3M-4.2%-8.8%+4.6%-2.3%
6M+11.4%-4.6%+16.0%+10.8%
YTD+64.5%+1.0%+63.5%+59.4%
1Y+87.8%+6.9%+80.9%+78.3%
3Y+35.8%+52.5%-16.8%+7.6%
5Y-8.6%+40.3%-48.8%-26.7%
All+681.6%+97.7%+583.9%+423.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling